TLPH
TALPHERA, INC.
TALPHERA, INC. (TLPH) has 16 SEC Form 4 filings (22 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jun 24, 2026.
Insiders have net bought $276K over the trailing 6 months.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Vincent J. Angotti
- Employees:13
- HQ:San Mateo, CA, US
- IPO:2011-02-11
Insider Buying
$276K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$69.0M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| CHIEF EXECUTIVE OFFICER | Purchase | 213,310 | $125K | Mar 25 | SEC ↗ | |
Angotti Vincent J.First filing | CHIEF EXECUTIVE OFFICER | Purchase | 105,364 | $86K | Feb 20 | SEC ↗ |
Dasu Badri NFirst filing | Chief Engineering Officer | Purchase | 35,000 | $28K | Feb 20 | SEC ↗ |
ASADORIAN RAFFIFirst filing | Chief Financial Officer | Purchase | 45,000 | $37K | Feb 20 | SEC ↗ |
Related companies
TALPHERA, INC. is in the Healthcare sector.